BRIEF published on 02/10/2026 at 17:50, 3 days 6 hours ago Mauna Kea Technologies obtient la certification CE MDR pour Cellvizio® Cellvizio Expansion Clinique Certification CE MDR Commercialisation Européenne Réglementation Des Technologies Médicales
BRIEF published on 02/10/2026 at 17:50, 3 days 6 hours ago Mauna Kea Technologies Secures CE MDR Certification for Cellvizio® Cellvizio Clinical Expansion CE MDR Certification European Commercialization MedTech Regulation
PRESS RELEASE published on 02/10/2026 at 17:45, 3 days 6 hours ago Inside Information / Other news releases Mauna Kea Technologies announces CE MDR certification for Cellvizio and probes, marking a key milestone in their European expansion strategy under new regulation Mauna Kea Technologies Cellvizio Regulatory Milestone CE MDR Certification European Expansion Strategy
BRIEF published on 01/21/2026 at 17:50, 23 days 6 hours ago Mauna Kea Technologies : Agenda financier 2026 dévoilé Calendrier Financier Conférences Investisseurs Mauna Kea Technologies Cellvizio Stratégies De Croissance
BRIEF published on 01/21/2026 at 17:50, 23 days 6 hours ago Mauna Kea Technologies: 2026 Financial Calendar Unveiled Investor Conferences Financial Calendar Growth Strategies Mauna Kea Technologies Cellvizio
PRESS RELEASE published on 01/21/2026 at 17:45, 23 days 6 hours ago Informations privilégiées / Autres communiqués Mauna Kea Technologies annonce son agenda financier 2026 et sa participation à des forums investisseurs pour présenter ses avancées. La société reprend sa communication après une restructuration en 2025 Partenariats Stratégiques Agenda Financier Mauna Kea Technologies Cellvizio Forums Investisseurs
BRIEF published on 11/20/2025 at 17:50, 2 months 23 days ago Approbation du Cellvizio Gen 3 de Mauna Kea en Chine Marché Chinois Mauna Kea Cellvizio Gen 3 Approbation NMPA Endoscopie
BRIEF published on 11/20/2025 at 17:50, 2 months 23 days ago Mauna Kea's Cellvizio Gen 3 receives approval in China NMPA Approval Chinese Market Mauna Kea Cellvizio Gen 3 Endoscopy
PRESS RELEASE published on 11/20/2025 at 17:45, 2 months 23 days ago Informations privilégiées / Autres communiqués Mauna Kea Technologies obtient l’approbation réglementaire en Chine pour sa plateforme Cellvizio® de nouvelle génération. L'entreprise évalue les options de commercialisation en Chine Chine Mauna Kea Technologies Approbation Réglementaire Cellvizio Gen 3 Endoscopie
PRESS RELEASE published on 11/20/2025 at 17:45, 2 months 23 days ago Inside Information / Other news releases Mauna Kea Technologies obtains NMPA approval in China for Cellvizio Gen 3 platform, aiming to commercialize independently. Approval valid until November 2030, reinforcing company's assets in China NMPA Approval China Commercialization Mauna Kea Technologies Cellvizio Gen 3 Platform
Published on 02/13/2026 at 22:15, 2 hours 25 minutes ago Storm Completes Sale of Miminiska Project for $5.8M and Outlines Plans for 2026
Published on 02/13/2026 at 17:45, 6 hours 55 minutes ago Eldorado Gold Closes $2.4 Million Strategic Investment in Gemdale Gold
Published on 02/13/2026 at 14:35, 10 hours 5 minutes ago Datametrex Received $500,000 Purchase Order For Data Centre Solutions
Published on 02/13/2026 at 14:30, 10 hours 10 minutes ago Golden Harp Resources Inc. Receives TSXV Final Acceptance and Closes Acquisition to Create District-Scale Copper Hill Land Package
Published on 02/13/2026 at 19:20, 5 hours 20 minutes ago Retail offering successfully completed and update on Euronext Growth Oslo listing
Published on 02/13/2026 at 19:01, 5 hours 38 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/13/2026 at 18:20, 6 hours 20 minutes ago GLOBAL TECHNOLOGY LEADERS LAUNCH TRUSTED TECH ALLIANCE
Published on 02/13/2026 at 18:07, 6 hours 32 minutes ago EQS-Adhoc: Delticom AG: Based on preliminary, unaudited figures for the FY 2025, full-year revenues are below the forecast, while operating EBITDA is expected to be at the upper end of the forecasted range
Published on 02/13/2026 at 17:58, 6 hours 41 minutes ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/13/2026 at 18:05, 6 hours 35 minutes ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/01/2026
Published on 02/13/2026 at 18:05, 6 hours 35 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/01/2026
Published on 02/13/2026 at 17:50, 6 hours 50 minutes ago Number of shares and voting rights - January 2026 (In French only)
Published on 02/13/2026 at 17:50, 6 hours 50 minutes ago Nombre total d'actions et droits de vote - janvier 2026
Published on 02/13/2026 at 17:34, 7 hours 5 minutes ago Déclaration des transactions sur actions propres réalisées du 02/02/2026 au 06/02/2026
